5
type virus consistently invaded the TG from the cornea, whereas invasion by the 131 C819S mutant was stochastic. Several animals infected with C819S lacked 132 detectable plaque-forming units in the TG but possessed viral DNA, consistent 133 with the establishment of a dormant infection. The C819S repaired virus 134 (C819S>C) and the C850S mutant virus were indistinguishable from wild type 135 ( Fig. 4C ). To determine if the animals producing wild-type yields of the C819S 136 mutant in the TG were the result of spontaneous reversion during infection, the 137 plaque diameter of one such recovered virus was measured and found to be 138 consistent with the C819S phenotype (Fig. 4D, left) . This isolate was also 139 confirmed to encode the C819S mutation ( Fig. 4D, right) . 140 141 Retrograde axonal transport is not dependent on the pUL37 deamidase. To 142 test whether mutation of the deamidase had an effect on retrograde axonal 143 transport, capsid transport dynamics were recorded within axons of primary 144 sensory neurons during the first hour post infection. Mutation of either C819 or 145 C850 had no significant impact on the directionality of capsid trafficking in axons 146 ( Fig. 5A) , the average number of stops and reversals displayed by individual 147 capsids ( Fig. 5B ), or the velocities and lengths of continuous retrograde runs 148 (Fig. 5C ). The distribution of retrograde velocities of each virus was consistently 149
Gaussian (R 2 ≥ 0.99 for each) and retrograde travel distances were accurately fit 150 as decaying exponentials (R 2 ≥ 0.91 for each), which is consistent with the 151 processive motion of wild-type HSV-1 (5). Furthermore, delivery of capsids to the 152 nuclear rims of primary sensory neurons was not notably impacted by either 153 cysteine mutation (Fig. 5D ). Collectively, these results indicate that the 154 deamidase indirectly promotes neuroinvasion by enhancing HSV-1 propagation 155 in peripheral tissues but does not directly contribute to retrograde axonal 156 transport and delivery to neural soma in sensory ganglia. where latent infections are established and maintained. Upon initial exposure 164 virus propagation within peripheral tissues, typically a mucosal epithelium, is 165 required for robust transmission into the nervous system, presumably by 166 increasing the number of viral particles encountering axon terminals at sites of 167 innervation (24, 25) . At least two viral proteins directly support the neuroinvasive 168 mechanism. The pUL36 large tegument protein promotes transmission from 169 epithelial tissues to nerve endings and subsequently tethers capsids delivered 170 into the cytosol of axon terminals to the dynein/dynactin microtubule motor 171 complex to drive retrograde axonal transport to sensory ganglia (12, 18) . The 172 pUL37 tegument protein sustains dynein-based microtubule transport by 173 restraining opposing plus-end motion (22). Consistent with these roles, pUL36 174 and pUL37 remain attached to capsids upon entry into cells (2, 3, 5, 26) , with 175 pUL36 bound directly to the capsid surface (7, 9, 27, 28) and pUL37 bound to 176 pUL36 (10, 11, 29) such that pUL36 tethers pUL37 to the capsid (13). 177
Understanding how the pUL36 and pUL37 tegument proteins mediate 178 neuroinvasion is foundational to developing vectors for neural gene delivery and 179
vaccination. 180
The HSV-1 pUL37 tegument protein was recently found to house a 181 deamidase activity that uses the cellular immune effectors, RIG-I and cGAS, as 182 substrates to antagonize interferon-based antiviral responses (16, 23) . The 183 deamidase also supports HSV-1 dissemination into the brain following 184 intraperitoneal challenge of mice, such that HSV-1 encoding a pUL37 C819S 185 catalytic site mutation is incapable of transmitting to the brain from the 186 peritoneum unless animals are knocked out for cGAS (23). This raises the 187 question of whether the deamidase supports propagation in the periphery that 188 indirectly enhances neuroinvasion, or if it also directly contributes to the 189 neuroinvasive process. The latter possibility is compelling given that the pUL37 190 deamidase is anchored on the capsid surface during axonal trafficking (2, 5, 26) .
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In this report, we examined whether neuroinvasion is dependent on the 192 deamidase using the mouse ocular model, which parallels the natural route of 193 HSV-1 infection: inoculation of a mucosal site and subsequent retrograde axonal 194 transport to the trigeminal ganglion of the peripheral nervous system. A pUL37 195 C819S mutant of HSV-1 strain F was produced to mimic the previously reported 196 catalytic mutant and was confirmed to fail to antagonize interferon expression 197 (16, 23) . In mice, the C819S mutant displayed reduced propagation in the 198 periphery that correlated to reduced neuroinvasion and production of recoverable 199 virus from the trigeminal ganglion. The decreased propagation in vivo correlated 200 to decreased propagation in culture, with the C819S mutant showing: (1) an 201 increased dependence on multiplicity of infection to efficiently infect Vero cells, 202
and (2) a decreased capacity to spread cell-to-cell in the plaque assay. 203
Unexpectedly, the plaque deficit was noted in primary human fibroblasts as well 204
as Vero cells, the latter of which are interferon deficient (30-32). The plaque 205 results in Vero cells indicates that the pUL37 deamidase does more than 206 antagonize interferon responses, or alternatively that RIG-I and cGAS trigger 207 antiviral activities independently of interferon production. 208
Despite the propagation defects in culture and in mice, the C819S mutant 209 was competent to invade the peripheral nervous system, and the capacity of the 210 mutant to promote retrograde axonal transport in primary cultured sensory 211 neurons was unimpaired. These findings raise the question of why the 212 deamidase is housed in a capsid-bound tegument protein that is a critical effector 213 of the transport mechanism. While only speculation can be offered on this point, 214
it is noteworthy that the catalytic cysteine is absent from the neuroinvasive 215 herpesviruses belonging to the varicellovirus genus ( Fig. 1 ), suggesting that the 216 deamidase may be absent from varicelloviruses. Nevertheless, representative 217 members of these two neuroinvasive genera (HSV-1, simplexvirus; PRV, 218 varicellovirus) engage in retrograde axonal transport dynamics that are 219 indistinguishable from one another, which could indicate that the deamidase is a 220 recent evolutionary adaptation of the simplexviruses and not a fundamental 221 component of the neuroinvasive apparatus (5). In this regard HSV-1 also 222 encodes an extended carboxyl terminus on pUL37 that modulates TRAF6 223 signaling (33), which is also absent from PRV. Together, these results 224 demonstrate a role for the pUL37 deamidase in HSV-1 propagation and spread 225 that is not directly required for retrograde axonal transport and invasion of the 226 reporter, HSVF-GS3217, was produced to monitor viral gene expression as an 253
indication of viral genome delivery to nuclei. To make HSVF-GS3217, an En 254 Passant template plasmid, pEP-CMV>tdTomato-NLS-in>pA, was first produced 255 by modifying a CMV-driven eGFP cassette from pEGFP-N1 (Clontech), such that 256 the CMV immediate early promoter was partially duplicated with an iscei::kan 257 cassette inserted between the duplicated sequences. The entire merodiploid 258 expression cassette was PCR amplified and the resulting linear dsDNA product 259 was transformed into GS1783 bacteria harboring the full-length HSV-1 strain F 260 infectious clone (35). Lambda red recombination was used to insert the product 261 into the HSV-1 US5 gene (encodes the gJ glycoprotein), and the kan cassette 262 was subsequently removed by a second round of lambda red recombination 263 following digestion with the ISceI homing enzyme. Missense mutations (Table 1 ) 264
were also introduced into the infectious clones by En Passant mutagenesis using 265 primers listed in Table 2 . Gemini Bioproducts). Cells were tested regularly for mycobacterium 274 contamination using the PlasmoTest kit (Invivogen) and authenticated by the 275 source. BGS levels were reduced to 2% during and after infection. HSV-1 strains 276 were produced by electroporation of infectious clones into Vero cells using an 277
ECM630 electroporation system (BTX Instrument Division, Harvard Apparatus). 278
Cells were pulsed once with the following settings: 220V, 950 µF, 0Ω. Serum 279 levels were reduced to 2% BGS approximately 12 h after electroporation. Virus 280 was harvested at a time at which 100% cells displayed pronounced cytopathic 281 effect (CPE) (typically 5 days post electroporation). Initial viral harvests were 282 subsequently passaged through Vero-Cre cells to excise the bacterial artificial 283 chromosome vector from the viral genome (36). 284
Single-step growth curve and plaque assays. Vero cells seeded in 6-well 286 plates were infected at a multiplicity of infection (MOI) of 10. After 1 h, 287 unabsorbed virus was inactivated with 1 ml of citrate buffer (pH 3.0), and cells 288 were washed and incubated in 2 ml of DMEM supplemented with 2% BGS at 289 37˚C, 5% CO 2 . At 2, 5, 8, 12, 24, and 30 hours post infection, HSV-1 was 290 harvested from Vero cells and supernatants. Titers were determined by plaque 291 assay on Vero cells overlaid with 2 ml methocel media (DMEM supplemented 292 with 2% BGS and 10mg/ml methyl cellulose) and allowed to expand for five days. 293
Images of at least 30 isolated plaques from each infection were acquired with a 294
Nikon Eclipse TE2000-U inverted microscope fitted with a 0.30 numerical 295 aperture (NA) 4 x objective and RFP filter set. To determine the plaque diameter, 296 the average of two orthogonal diameter measurements was calculated for each 297 plaque using ImageJ software. Plaque diameters were expressed as a 298 percentage of the diameter of wild-type HSV-1, which was always measured in 299 parallel. Data sets were plotted using GraphPad Prism 7 (GraphPad Software 300 Inc). 301 302 Primary neuronal culture. Dorsal root ganglia (DRG) from embryonic chicks 303 (E8-E10) were cultured on poly-DL-ornithine-and laminin-treated coverslips in 2 304 ml of F12 media (Invitrogen) containing nutrient mix: 0.08 g/ml bovine serum 305 albumin fraction V powder (VWR), 0.4 mg/ml crystalline bovine pancreas insulin 306 (Sigma-Aldrich), 0.4 µg/ml sodium selenite (VWR), 4 µg/ml avian transferrin 307 (Intercell Technology) and 5 ng/ml nerve growth factor (NGF; Sigma-Aldrich). 308
DRGs from embryonic rats (E18) (Neuromics) were cultured as described above 309
and supplemented with human holo-transferrin (Sigma-Aldrich). A single explant 310 was cultured on each cover slip for 2 to 3 days and infected with 5 x 10 7 PFU/ml 311 of virus for five minutes. Cover slips were subsequently mounted to a glass cover 312 slide and time-lapse imaging of mCherry emissions was achieved by automated 313 sequential capture using 150 ms exposures between 0.5-1.0 hpi for retrograde 314 transport analysis, and 3.0-4.0 hpi for nuclear rim formation. 315 11 316 Fluorescence microscopy and image analysis. Virus transport dynamics were 317 monitored in primary DRG explants. Explants were infected in 2 ml of F12 media 318
with 5 x 10 7 PFU/ml of HSV-1 (WT and mutants) from 0.5-1.0 hpi. Time-lapse 319 images were captured using an inverted wide-field Nikon Eclipse TE2000-U 320 microscope fitted with a 60x/1.4 NA objective and a CascadeII:512 electron-321 multiplying charge-coupled device (EM-CCD; Photometrics). The microscope 322 was housed in a 37 o environmental box (In Vivo Scientific). Moving particles were 323 Devices). The multi-line tool was again employed to trace kymograph paths, and 329 the fraction of time that a particle was stopped, moving anterograde, or moving 330 retrograde was calculated for each particle. Forward distance and forward 331 velocity for each particle were also measured and filtered for distances >0.5 332 microns to control for random diffusion of virions. Graphs were created in 333 GraphPad Prism 7. 334 335 Ethics statement. All procedures confirmed to NIH guidelines for work with 336 laboratory animals and were approved by the Institutional Animal Care and Use 337
Committee of Northwestern University (IS00003334). Fertilized chicken eggs 338
were obtained from Sunnyside, Inc. and tissue was harvested between 339 embryonic day 8 and 10. 340 341 In vivo methods. Intraocular HSV-1 infections of BALB/c mice (9 week old; 342 Jackson Lab) were carried out in animals anesthetized with an intraperitoneal 343 injection of ketamine (86.98 mg/kg) and xylazine (13.04 mg/kg) mixture. Each 344 cornea was lightly abraded 10 times in a crosshatched pattern with a 25-gauge 345 needle, and 1 x 10 6 PFU of HSV-1 was administered to the cornea surface. Prior 346 to infection, the virus stock was sonicated and centrifuged for 2 min at 300 x g to 347 remove cell debris. Tears containing shed virus were collected by proptosing 348 each eye and swabbing with a damp cotton applicator three times in a circular 349 pattern around the eye. Two independent experiments were performed to collect 350 virus within the tear films of infected mice at 12, 16, and 20 hpi, and at 24, 48, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 361 sulfate) supplemented with protease inhibitors (2.5 mM sodium fluoride, 1 mM 362 sodium orthovanadate, 0.5 mM phenylmethylsulphonyl fluoride, 100 l of protease 363 inhibitor cocktail [Sigma]). Lysates were rotated for 30 minutes, sonicated for 364 three 1.5-s pulses, and rotated for an additional 30 min. Lysates were then spun 365 at 13,000 X g for 20 min, and the supernatants were harvested. 2.5% of the 366 supernatant from each lysate was mixed with 2X final sample buffer (62.5 mM 367
Tris [pH 6.8], 2% SDS, 10% glycerol, 0.01% bromophenol blue) supplemented 368 with 50 mM dithiothreitol (DTT) and loaded onto an acrylamide gel for SDS-369 PAGE. Blots were probed with an antibody raised against HSV-1 pUL37 (HA108, 370
Virusys; diluted 1:3300) and an antibody raised against HSV-1 VP5 (diluted to 10 ng/μl and mixed with 10 μl of master mix to form cDNA. Run settings were 395 25˚C for 10 minutes, 37˚C for 2 hours, and 85˚C for 5 minutes. cDNA was diluted 396 1:5 with RNAse-free water and used in a qPCR reaction as described above. The 
VZV BWHV1 varicelloviruses simplexviruses FIGURE 1: The pUL37 residues C819 and C850 are conserved within the simplexvirus genera. Alignment of the deamidase region of pUL37 across 24 members of the alpha-herpesviruses subfamily spanning the simplexvirus and varicellovirus genera. The HSV-1 residues C819 and C850 are circled in blue. 
